MEMPHIS, Tenn. – (August 12, 2014) – Christie Medical Holdings, Inc., a global leader in mobile vascular imaging systems, and Wolfson Children’s Hospital, today announced an agreement to replace all current peripheral vascular access visualization devices at the hospital with 17 VeinViewers through Christie’s FreshStart program. The hospital was using the latest version of a hand-held, red laser-based competitive illumination device, but switched to Christie’s VeinViewer. Only VeinViewer can provide pre-, during and post-access benefits throughout the entire vascular access procedure and has been shown through clinical studies to increase both first stick success and patient satisfaction up to 100 percent while reducing medically unnecessary PICC lines by over 30 percent.
“It is extremely important to the administration of Wolfson Children’s Hospital to provide the nursing staff with the best tools for performing IV starts on children,” said Veronica Scott- Fulton, vice president, operations and patient care services, Wolfson Children’s Hospital. “We believe that the technology and support provided by Christie Medical are the best available and will result in fewer sticks and improved patient and family satisfaction. We are pleased to partner with Christie Medical to make Wolfson Children’s a Vascular Access Center of Excellence.”
Holly Hess of Wolfson Children’s Hospital added, “In my experience as a pediatric vascular access clinician, I have the opportunity to use various types of vein visualization devices. I find the Christie VeinViewer products to have a clearly superior, crisp image that shows peripheral vasculature in a way that enhances the practitioner’s ability to find and access veins.”
“Our FreshStart Program provides a significant financial benefit to all medical facilities who want to replace their unsatisfactory vein illumination devices with the VeinViewer solution. The proven results of our technology backed by our revolutionary Christie Assure Program, provides a solution that is trusted to deliver results year after year,” said Chris Schnee, general manager and vice president of Sales and Marketing at Christie Medical Holdings, Inc.
The Christie Assure program is a comprehensive set of services including a five-year utilization training program, five-year warranty, five-year clinical education provision for hospital medical staff and five-year upgrade program to the latest product platforms from Christie. An industry-first, the Christie Assure Program represents a significant leadership investment in seeing the end customer achieve utilization and results through Christie technologies. “In today’s healthcare market there is no room for neat technology that does not deliver results,” added Schnee. “Today’s hospitals demand technology that is proven to work and is supported by a company trusted to be there for the long-term. We are pleased that Wolfson Children’s Hospital has placed trust in our products, technology and service by replacing their current devices with Christie’s VeinViewer portfolio of products.”
VeinViewer Technology Backed by Christie’s Long History of Technical Achievements
VeinViewer technology was developed with the aid of the engineering capabilities and resources of parent company Christie Digital Systems, a leading global visual technology firm with more than 80 years of experience in the projection systems industry. VeinViewer is the first and only device on the market to use: harmless near-infrared light, DLP® technologies, exclusive technology such as Active Vascular Imaging Navigation (AVIN™) providing the demanded Pre, During and Post-access (PDP) benefits, TrueView imaging accuracy in projected vein-widths which is three to ten times more accurate than competition, and technologies such as Df2 (Digital full field) to illuminate the only real-time HD digital image of subcutaneous vasculature and blood patterns directly onto the skin surface . Although designed for assistance in IV starts and blood draws, VeinViewer has proven beneficial in spider and varicose vein treatment.
To learn more about Christie product offerings: VeinViewer Vision, VeinViewer VisionXTND and VeinViewer Flex, please visitwww.christiemed.com.
About Wolfson Children’s Hospital
Wolfson Children’s Hospital in Jacksonville, Florida, serves as our region’s pediatric referral center and only hospital just for kids. The 213-bed, patient- and family-centered hospital features an environment filled with bright colors, warm smiles and the latest children’s medical technology. At Wolfson Children’s, nationally recognized pediatric specialists representing nearly every medical and surgical specialty work with pediatricians to provide care for children of all ages with congenital heart conditions, cancer, neurological disorders, orthopaedic conditions, behavioral health disorders, and more. The hospital is staffed by pediatric nurses and other healthcare professionals specially trained to work with children. Wolfson Children’s pediatric partners include Nemours Children’s Clinic, the University of Florida Jacksonville, and Mayo Clinic Florida. For additional information, please visit wolfsonchildrens.org.
About Christie Medical Holdings, Inc.
Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature as a real time HD image, directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit www.christiemed.com.
Follow Christie at:
Follow us on Twitter @veinviewer
Christie® is a registered trademark of Christie Digital Systems USA, Inc., registered in the United States of America and certain other countries.
DLP® is a registered trademark of Texas Instruments.